Skip to main content
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. — Investor Relations & Filings

Ticker · SCNI ISIN · US09073Q3039 US Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2024-02-02 Regulatory Filings
Country US United States of America
Listing US SCNI

About Scinai Immunotherapeutics Ltd.

https://www.scinai.com/

Scinai Immunotherapeutics Ltd. is a clinical-stage biopharmaceutical company operating through two complementary business units. Its internal research and development division focuses on developing innovative biological products for inflammation and immunology (I&I), targeting autoimmune and infectious diseases. The core of its therapeutic pipeline is a platform of Alpaca-derived nanosized antibodies (NanoAbs or VHH-antibodies), developed for conditions such as psoriasis and asthma. The company's second unit, Scinai Bioservices, is a Contract Development and Manufacturing Organization (CDMO). It provides end-to-end services to biotech companies, supporting drug development from early research and process development through to cGMP-compliant manufacturing for clinical trials up to Phase 3.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The provided document text appears to be heavily encoded or corrupted, containing mostly non-readable characters and no discernible structured content, titles, or keywords related to any specific financial filing type. There are no clear indications of report titles, fiscal periods, regulatory bodies, or any typical filing content. The document length is 15,000 characters, which is substantial, but the content does not contain meaningful text to classify as a financial report or announcement. Given the lack of identifiable information and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for filings that do not fit other specific types.
2024-02-02 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is a Form F-3 Registration Statement filed with the SEC, which is a type of registration statement used for securities offerings. It includes a prospectus for the resale of American Depositary Shares by selling shareholders. The content focuses on the registration and offering of securities, including details about the offering, selling shareholders, risk factors, and legal matters. This is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to securities registration and offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS.
2024-01-30 English
AMENDMENT NO. 2 TO SCHEDULE 13G
Major Shareholding Notification
2024-01-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Investor Presentation Classification · 95% confidence The document is a Form 6-K filing, which is a report of a foreign private issuer submitted to the SEC. It includes an explanatory note about an updated presentation being furnished as Exhibit 99.1. The document itself does not contain detailed financial statements or comprehensive analysis but rather provides a summary presentation update. The length is only 2122 characters, indicating it is a brief filing. According to the rules, such filings that provide presentations or updates without full financial reports are best classified as Investor Presentations (IP).
2024-01-18 English
Regulatory Filings 2024
Regulatory Filings
2024-01-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes an explanatory note stating that an updated presentation about the company's business is furnished as Exhibit 99.1. The document itself is short (2118 characters) and primarily serves to provide the presentation as an exhibit. There is no detailed financial data or comprehensive report content within this text. According to the MENU VS MEAL RULE, this is an announcement of a report (the presentation) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2024-01-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.